Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
|
Mosaic ImmunoEngineering Inc. (PTSC)
|
Add to portfolio |
|
|
|
| Price: |
$1.02
| | Metrics |
| OS: |
7.24
|
M
| |
|
|
| Market cap: |
$7.39
|
M
| |
|
|
|
Net debt:
|
$553.7
|
k
| |
|
|
|
EV:
|
$7.94
|
M
| | | |
| | | | | |
| TTM Valuation | | | |
|
EBITDA
|
($1.8)
|
M
| |
|
|
|
EBIT
|
($1.8)
|
M
| |
|
|
| EPS |
($0.15)
| |
|
|
|
|
| |
|
|
|
Recent News + Filings (All items)
|
Revenue Mix by Segment
|
Financial Summary (All financials)
| In millions, except per share items | Dec-31-22 | Dec-31-21 | May-31-20 | May-31-19 | May-31-18 | May-31-17 | May-31-16 | May-31-15 |
| Revenues | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Cost of goods sold | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Gross profit | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Gross margin | | | | | | | | |
| Selling, general and administrative | | | 1.0 | 0.7 | 1.0 | 1.2 | 1.6 | 1.4 |
| Research and development | 1.0 | 1.5 | | | | | | |
| General and administrative | 1.6 | 2.0 | | | | | | |
| EBIT | -2.6 | -3.5 | -1.0 | -0.8 | -1.3 | -0.1 | -1.6 | -1.6 |
| EBIT margin | | | | | | | | |
| Pre-tax income | -2.4 | -3.7 | -1.1 | -0.8 | -1.3 | 0.0 | -1.3 | -1.5 |
| Income taxes | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Tax rate | | | | | 4.0% | | | |
| Earnings from continuing ops | -2.4 | -3.7 | -1.1 | -0.8 | -1.2 | 0.0 | -1.3 | -1.5 |
| Earnings from discontinued ops | | | | | | | | 0.0 |
| Net income | -2.4 | -3.7 | -1.1 | -0.8 | -1.2 | 0.0 | -1.3 | -1.5 |
| Net margin | | | | | | | | |
| |
| Diluted EPS | ($0.33) | ($0.55) | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Shares outstanding (diluted) | 7.2 | 6.7 | 398.5 | 398.5 | 398.5 | 398.5 | 398.5 | 398.5 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|
|